Suppr超能文献

加纳北部博尔加坦加市未经处方使用抗疟药物治疗疟疾的情况。

The use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga municipality, northern Ghana.

机构信息

Ghana Health Service, Bolgatanga Regional Hospital, Bolgatanga, Ghana.

出版信息

Malar J. 2013 Jul 31;12:266. doi: 10.1186/1475-2875-12-266.

Abstract

BACKGROUND

The use of non-prescribed anti-malarial drugs can lead to treatment failure and development of drug-resistant parasites. This study investigated the use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga Municipality of northern Ghana.

METHODS

This was a cross-sectional survey of a random sample of 392 adults and children with episodes of malaria in the last four weeks prior to the study.

RESULTS

Majority of survey respondents 96.9% (380) knew the symptoms of malaria, 75% (294) knew the causes of malaria and 93.1% (365) were aware of mode of transmission of malaria. The use of non-prescribed anti-malarial drugs was 16.8% (95% CI: 13.3-21.0) among the respondents. About 56% (95% CI: 43.3-68.3) of the respondents who took non-prescribed anti-malaria drugs took non-artemisinin-based combination therapy (chloroquine, artemether, amodiaquine and sulphadoxine-pyrimethamine). Respondents above five years of age were more likely to use non-prescribed anti-malarial drugs than those below five years of age [P < 0.001]; respondents who knew the right source of malaria treatment were less likely to use non-prescribed anti-malarial drugs than those who did not [P = 0.002]. Respondents using non-prescribed anti-malarials were influenced by people around them who used non-prescribed anti-malarials. Thus, these respondents were more likely to use non-prescribed anti-malarials than those who were not influenced [P = 0.004].

CONCLUSIONS

Respondents' knowledge of malaria treatment and the influence of people using non-prescribed anti-malarials are factors affecting use of non-prescribed anti-malarials. The study concludes that there is high use of non-prescribed anti-malarial drugs in the municipality and most of the non-prescribed anti-malarias were non-artemisinin-based combination therapy. The study recommends education of the general public and chemical sellers to reduce the use of non-prescribe anti-malaria drugs.

摘要

背景

非处方抗疟药物的使用可能导致治疗失败和耐药寄生虫的产生。本研究调查了加纳北部博尔加坦加市(Bolgatanga Municipality)使用非处方抗疟药物治疗疟疾的情况。

方法

这是一项横断面调查,对研究前四周内有疟疾发作的 392 名成人和儿童进行了随机抽样。

结果

大多数调查对象(96.9%,380 人)知道疟疾的症状,75%(294 人)知道疟疾的病因,93.1%(365 人)了解疟疾的传播途径。受访者中使用非处方抗疟药物的比例为 16.8%(95%CI:13.3-21.0)。约 56%(95%CI:43.3-68.3)服用非处方抗疟药物的受访者服用的是非青蒿素类联合疗法(氯喹、青蒿素、阿莫地喹和磺胺多辛-乙胺嘧啶)。五岁以上的受访者比五岁以下的受访者更有可能使用非处方抗疟药物[P<0.001];知道疟疾治疗正确来源的受访者比不知道的受访者更不可能使用非处方抗疟药物[P=0.002]。使用非处方抗疟药物的受访者受到周围使用非处方抗疟药物的人的影响。因此,这些受访者比不受影响的受访者更有可能使用非处方抗疟药物[P=0.004]。

结论

受访者对疟疾治疗的了解以及使用非处方抗疟药物的人的影响是影响使用非处方抗疟药物的因素。该研究得出结论,该市非处方抗疟药物的使用量很高,且大多数非处方抗疟药物是非青蒿素类联合疗法。该研究建议对公众和化学药品销售者进行教育,以减少非处方抗疟药物的使用。

相似文献

8
Receipt of antimalarials among children aged 6-59 months in Nigeria from 2010 to 2021.
Malar J. 2024 Aug 19;23(1):249. doi: 10.1186/s12936-024-05075-x.

引用本文的文献

2
The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso.
Malar J. 2023 Sep 13;22(1):269. doi: 10.1186/s12936-023-04705-0.
3
The Problem of Antimalarial-Drug Abuse by the Inhabitants of Ghana.
Medicina (Kaunas). 2023 Jan 29;59(2):257. doi: 10.3390/medicina59020257.
4
Individual and Contextual Factors Associated With Malaria Among Children 6-59 Months in Burkina Faso.
Int J Public Health. 2023 Feb 6;68:1605347. doi: 10.3389/ijph.2023.1605347. eCollection 2023.
5
Zero malaria: a mirage or reality for populations of sub-Saharan Africa in health transition.
Malar J. 2022 Nov 4;21(1):314. doi: 10.1186/s12936-022-04340-1.
8
Two years post affordable medicines facility for malaria program: availability and prices of anti-malarial drugs in central Ghana.
J Pharm Policy Pract. 2017 Apr 28;10:15. doi: 10.1186/s40545-017-0103-0. eCollection 2017.

本文引用的文献

1
US Department of Defense contributions to malaria surveillance.
Lancet Infect Dis. 2013 Apr;13(4):293-4. doi: 10.1016/S1473-3099(13)70065-3.
2
Artemisinin resistance or artemisinin-based combination therapy resistance?
Lancet Infect Dis. 2013 Feb;13(2):114-5. doi: 10.1016/S1473-3099(12)70349-3.
3
Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia.
Clin Infect Dis. 2010 Dec 1;51(11):e82-9. doi: 10.1086/657120. Epub 2010 Oct 28.
6
Is community-based health insurance an equitable strategy for paying for healthcare? Experiences from southeast Nigeria.
Health Policy. 2009 Sep;92(1):96-102. doi: 10.1016/j.healthpol.2009.02.007. Epub 2009 Apr 5.
8
Malaria treatment in the retail sector: knowledge and practices of drug sellers in rural Tanzania.
BMC Public Health. 2008 May 9;8:157. doi: 10.1186/1471-2458-8-157.
9
Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border.
Emerg Infect Dis. 2008 May;14(5):716-9. doi: 10.3201/eid1405.071601.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验